OUR INVESTMENT STRATEGY
We believe that technology is key to finding new ways to create value and to increase efficiency and quality in healthcare delivery.
Our investment strategy is well aligned with the dynamics of the MedTech industry and is based upon our team’s diverse knowledge and experience gained from investing in over 30 opportunities in the MedTech sector with more than 20 exits to date.
Along the way, we stay close to industry participants seeking MedTech acquisitions. The alignment of our prospective investments with potential acquirers is an integral part of our investment strategy.
Most often, we lead financing rounds and work to ensure companies are appropriately financed to achieve clear inflection milestones necessary for success. BioVentures MedTech Funds will typically be represented on the board, and whichever member or members of our team are best suited to the investment and the company will play an active role of support and guidance. We are entrepreneurs who understand and align with management to obtain the best results for all stakeholders in advancing new medical technologies.
The strategy around BioVentures MedTech Funds is rooted in our team’s ability to identify and invest in promising opportunities that:
Provide meaningful, disruptive innovation that delivers higher quality care solutions
Respond to unmet needs and emerging healthcare trends
Enable cost-effective paradigm shifts in the delivery of current therapies and diagnoses
Deliver improved healthcare provider and payer economics and physician incentives
Align with potential acquirers’ strategic needs
seeks to deploy between
$10-25MM
into companies that have removed essentially all development and regulatory risk and are entering a growth phase that will lead to successful exit within 3 years.seeks to deploy between